17 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18647137 | STEM CELL DERIVED PANCREATIC ISLET DIFFERENTIATION | DICKINSON, PAUL W | 1618 | Non-Final OA | Apr 26, 2024 |
| 18566176 | SOLID DOSAGE FORMS AND DOSING REGIMENS COMPRISING (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUOROMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE | RAO, PADMAJA S | 1627 | Non-Final OA | Dec 01, 2023 |
| 18248068 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | FETTEROLF, BRANDON J | 1626 | Final Rejection | Apr 06, 2023 |
| 18030529 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | FETTEROLF, BRANDON J | 1626 | Final Rejection | Apr 06, 2023 |
| 18030527 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | FETTEROLF, BRANDON J | 1626 | Final Rejection | Apr 06, 2023 |
| 18030518 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | Non-Final OA | Apr 06, 2023 |
| 18030530 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | FETTEROLF, BRANDON J | 1626 | Final Rejection | Apr 06, 2023 |
| 18248071 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | FETTEROLF, BRANDON J | 1626 | Final Rejection | Apr 06, 2023 |
| 18030537 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | FETTEROLF, BRANDON J | 1626 | Final Rejection | Apr 06, 2023 |
| 18018787 | IN VITRO DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS | ROGERS, ERIC JASON | 1638 | Non-Final OA | Jan 30, 2023 |
| 17916484 | INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | O DELL, DAVID K | 1621 | Non-Final OA | Sep 30, 2022 |
| 17820773 | METHOD FOR TREATING CANCER USING A COMBINATION OF DNA DAMAGING AGENTS AND ATR INHIBITORS | HOWELL, THEODORE R | 1628 | Non-Final OA | Aug 18, 2022 |
| 17669874 | PANCREATIC DIFFERENTIATION | BATES, KEENAN ALEXANDER | 1631 | Final Rejection | Feb 11, 2022 |
| 17560680 | ENHANCED DIFFERENTIATION OF BETA CELLS | NGUYEN, NGHI V | 1653 | Non-Final OA | Dec 23, 2021 |
| 17345256 | INHIBITORS OF APOL1 AND METHODS OF USING SAME | CHICKS, ASHLI ARIANA | 1626 | Non-Final OA | Jun 11, 2021 |
| 17293632 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | LEE, HOI YAN NMN | 1693 | Non-Final OA | May 13, 2021 |
| 16845280 | GENE-EDITING SYSTEMS FOR MODIFYING A SCN9A OR SCN10A GENE AND METHODS OF USE THEREOF | SHIN, DANA H | 1635 | Final Rejection | Apr 10, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial